Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma;Associação de emblica, licorice e belides como alternativa à hidroquinona no tratamento clínico do melasma

Anais Brasileiros de Dermatologia

Volumn 85, Issue 5, 2010, Pages 613-620

  Costa, Adilson ^a,b,c   Moisés, Thaís Abdalla ^c   Cordero, Tatiana ^a   Alves, Caroline Romanelli Tiburcio ^c   Marmirori, Juliana ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

Author keywords

Hydroquinones; Melanosis; Phyllanthus Emblica

Indexed keywords

BELLIS PERENNIS EXTRACT; CLARIDERM CLEAR; EMBLICA OFFICINALIS EXTRACT; GLYCYRRHIZA EXTRACT; HYDROQUINONE; PADIMATE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACNE; ADULT; ARTICLE; BELLIS PERENNIS; BURNING SENSATION; CHLOASMA; CREAM; DEPIGMENTATION; DRUG EFFICACY; DRUG SAFETY; EMBLICA OFFICINALIS; EVENING DOSAGE; FEMALE; GLYCYRRHIZA; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; PAPULE; PHASE 4 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SINGLE BLIND PROCEDURE; SKIN MANIFESTATION;

EID: 78650483350     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/s0365-05962010000500003     Document Type: Article

References (30)

1. Willis I. Cutaneous heat: a potential environmental factor in the development of melasma. Cosmet Dermatol. 2004;17:387-90.
2. Katsambas AD, Statigos AJ, Lotti TM. Melasma. In: AD Katsambas, TM Lotti, eds. European Handbook of Dermatological Treatments, 2nd ed. Berlin: Springer-Verlag, 2003. p. 336-41.
3. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453-7.
4. Sanchez N P, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981;4:698-710.
5. Bolanca I, Bolanca Z, Kuna K, Vukovi A, Tuckar N, Herman R, Grubisi G. Chloasma - the mask of pregnancy. Coll Antropol. 2008;32(Suppl 2):139-41.
6. Katsambas A, Antoniou Ch. Melasma. Classification and treatment. J Eur Acad Dermatol Venereol. 1995;4:217-23.
7. Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol. 2006;54(5 Suppl 2):272-81.
8. Torok HM. A comprehensive review of the long-term and short-term treatment of melasma with triple combination cream. Am J Clin Dermatol. 2006;7:223-30.
9. Ferreira Cestari T, Hassun K, Sittart A, de Lourdes Viegas M. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol. 2007;6:36-9.
10. Nordlund JJ, Grimes PE, Ortonne J P. The safety of hydroquinone. J Euro Acad Dermatol Venerol. 2006;20:781-7.
11. Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20:308-13.
12. Heldermann M. Skin lightening the natural way. COSSMA. 2005:8: 31.
13. Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998;11:355-61.
14. Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc. 2008;13:20-4.
15. Hruza LL, Pentland A P. Mechanisms of UV-induced inflammation. J Invest Dermatol. 1993;100:35S-41S.
16. Chaudhurl RK. Low molecular weight tannins as a new class of skin-lightening agent. J Cosmet Sci. 2002;53:305-6.
17. Chaudhuri R K. Emblica cascading antioxidant: a novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol. 2002;15:374-80.
18. Sumitra M, Manikandan P, Gayathri VS, Mahendran P, Suguna L. Emblica officinalis exerts wound healing action through upregulation. of collagen and extracellular signal-regulated kinases (ERK1/2). Wound Repair Regen. 2009;17:99-107.
19. Pytel RF, Silva LVN, Nunes AS, Gesztesi JL, Costa A. Estudo in vitro de atividade anti-radicalar por quantificação de peróxidos cutâneos. An Bras Dermatol. 2005;80(Supl 3):323-8.
20. Morganti P, Bruno C, Guarneri F, Cardillo A, Del Ciotto P, Valenzano F. Role of topical and nutritional supplement to modify the oxidative stress. Int J Cosmet Sci. 2002;24:331-9.
21. Benchikhi H, Razoli H, Lakhdar H. Sunscreens: use in pregnant women in Casablanca. Ann Dermatol Venereol. 2002;129:387-90.
22. Wang CC, Hui CY, Sue YM, Wong WR, Hong HS. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg. 2004;30:1196-200.
23. Salem A, Gamil H, Ramadan A, Harras M, Amer A. Melasma: Treatment evaluation. J Cosmet Laser Ther. 2009;11:1-5.
24. Baurin N, Arnoult E, Scior T, Do QT, Bernard P. Preliminary screening of some tropical plants for anti-tyrosinase activity. J Etnopharmacol. 2002;82:155-8.
25. Costa A, Alchorne MMA, Michalany NS, Lima HC. Acne vulgar: estudo piloto de avaliação do uso oral de ácidos graxos essenciais por meio de análises clínica, digital e histopatológica. An Bras Dermatol. 2007;82:129-34.
26. Pootongkam S, Asawanonda P. Purpura-free treatment of lentigines using a long-pulsed 595 nm pulsed dye laser with compression handpiece: a randomized, controlled study. J Drugs Dermatol. 2009;8(11 Suppl): S18-24.
27. Yu CS, Yeung CK, Shek SY, Tse RK, Kono T, Chan HH. Combined infrared light and bipolar radiofrequency for skin tightening in Asians. Lasers Surg Med. 2007;39:471-5.
28. Kulick MI, Gajjar NA. Analysis of histologic and clinical changes associated with Polaris WR treatment of facial wrinkles. Aesthet Surg J. 2007;27:32-46.
29. Taylor S, Westerhof W, Im S, Lim J. Noinvasive techniques for the evaluation of the skin. J Am Acad Dermatol. 2006;54(5 Suppl 2): S282-90.
30. Canfieldsci.com [homepage]. Dermirli R, Otto P, Viswanathan R, Patwardhan S, Larkey J. RBX Technology Overview. [Acesso 19 Jul. 2009] Disponível em: http://www.canfieldsci.com/FileLibrary/RBX%20 tech%20overview-LoRz1.pdf.